| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Skye Bioscience, Inc. | Chief Development Officer | Common Stock | 82,259 | $410,472 | $4.99 | 18 Nov 2024 | Direct |
| Skye Bioscience, Inc. | Chief Development Officer | Stock Option (Right to Buy) | 150,000 | $2,125 | $0.0170 | 24 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | 24 Feb 2025 | 1 | $0 | 4 | Chief Development Officer | 26 Feb 2025, 17:38 |
| SKYE | Skye Bioscience, Inc. | 15 Nov 2024 | 2 | -$97,722 | 4 | Chief Development Officer | 20 Nov 2024, 08:23 |
| SKYE | Skye Bioscience, Inc. | 28 Oct 2024 | 1 | $0 | 4 | Chief Development Officer | 30 Oct 2024, 20:33 |
| SKYE | Skye Bioscience, Inc. | 29 Feb 2024 | 2 | $0 | 4 | Chief Development Officer | 04 Mar 2024, 06:19 |
| SKYE | Skye Bioscience, Inc. | 29 Feb 2024 | 0 | $0 | 3 | Chief Development Officer | 04 Mar 2024, 06:17 |